Certain diabetes drugs may thwart dementiaOctober 21, 2019DiabetesNeurologyEndocrinologyMental Health
Take drug, patient-level factors into account for when to end antiresorptive therapyOctober 18, 2019RheumatologyEndocrinology
SSRIs may reduce fecundability, live birth rate in reproductive-age womenOctober 15, 2019Women's HealthMental HealthEndocrinology
Multiple zoledronic acid doses may be needed after stopping denosumabOctober 14, 2019EndocrinologyRheumatology
Much work to be done in optimizing treatment for transgender childrenOctober 10, 2019Transgender HealthPediatricsEndocrinology
Consider cognitive reframing of osteoporosis to improve adherenceOctober 3, 2019EndocrinologyRheumatology
Osteoporosis remains a costly burden to older U.S. adultsOctober 3, 2019EndocrinologyRheumatologyGeriatrics
Panel releases guidelines for red meat, processed meat consumptionSeptember 30, 2019CardiologyDiabetesEndocrinologyOncologyPreventive Care
FDA adds diabetic kidney disease, heart failure indications to canagliflozinSeptember 30, 2019DiabetesCardiologyNephrologyEndocrinology
Vitamin D does not improve bone density, structure in healthy patientsSeptember 23, 2019EndocrinologyGeriatricsWomen's Health
Machine learning–derived risk score predicts heart failure risk in diabetes patientsSeptember 22, 2019CardiologyDiabetesEndocrinology
Try testosterone for some women with sexual dysfunction, but not othersSeptember 11, 2019EndocrinologyWomen's Health
DAPA-HF results transform dapagliflozin from antidiabetic to heart failure drugSeptember 2, 2019DiabetesCardiologyEndocrinology
Zoledronate maintains bone loss after denosumab discontinuationAugust 28, 2019RheumatologyWomen's HealthEndocrinology
